Lido Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,911
| Closed | -$206K | – | 925 |
|
|
2022
Q1 | $206K | Buy |
6,911
+486
| +8% | +$14.5K | ﹤0.01% | 834 |
|
|
2021
Q4 | $170K | Sell |
6,425
-4,329
| -40% | -$115K | ﹤0.01% | 853 |
|
|
2021
Q3 | $390K | Buy |
10,754
+1,647
| +18% | +$59.7K | 0.01% | 585 |
|
|
2021
Q2 | $395K | Buy |
9,107
+2,326
| +34% | +$101K | 0.01% | 522 |
|
|
2021
Q1 | $232K | Sell |
6,781
-6,694
| -50% | -$229K | ﹤0.01% | 662 |
|
|
2020
Q4 | $471K | Buy |
13,475
+6,329
| +89% | +$221K | 0.01% | 437 |
|
|
2020
Q3 | $171K | Buy |
7,146
+1,382
| +24% | +$33.1K | ﹤0.01% | 523 |
|
|
2020
Q2 | $105K | Sell |
5,764
-155
| -3% | -$2.82K | ﹤0.01% | 499 |
|
|
2020
Q1 | $92K | Buy |
5,919
+626
| +12% | +$9.73K | ﹤0.01% | 495 |
|
|
2019
Q4 | $113K | Sell |
5,293
-114
| -2% | -$2.43K | ﹤0.01% | 574 |
|
|
2019
Q3 | $101K | Sell |
5,407
-8,943
| -62% | -$167K | 0.01% | 504 |
|
|
2019
Q2 | $374K | Buy |
14,350
+1,383
| +11% | +$36K | 0.02% | 335 |
|
|
2019
Q1 | $333K | Buy |
12,967
+1,655
| +15% | +$42.5K | 0.02% | 333 |
|
|
2018
Q4 | $260K | Buy |
11,312
+1,852
| +20% | +$42.6K | 0.03% | 321 |
|
|
2018
Q3 | $303K | Buy |
9,460
+1,397
| +17% | +$44.7K | 0.03% | 314 |
|
|
2018
Q2 | $228K | Buy |
8,063
+2,533
| +46% | +$71.6K | 0.03% | 348 |
|
|
2018
Q1 | $195K | Buy |
+5,530
| New | +$195K | 0.03% | 353 |
|